Nebula Research & Development LLC Amneal Pharmaceuticals, Inc. Transaction History
Nebula Research & Development LLC
- $1.17 Trillion
- Q2 2025
A detailed history of Nebula Research & Development LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 121,599 shares of AMRX stock, worth $1.26 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
121,599
Previous 56,363
115.74%
Holding current value
$1.26 Million
Previous $472 Million
108.28%
% of portfolio
0.08%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$182 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$128 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$121 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$117 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$58.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.57B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...